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1. Introduction
1. 1. The object of the research
The object of the study is uterine fibroids in women of early reproductive age.
1. 2. Problem description
Uterine fibroids are among the most common benign tumors of the pelvic organs, which 
occurs in women of all ethnic groups. In women under the age of 35, the frequency of UF is almost 
60 %, in women under the age of 50–80 % and its prevalence increases every year, especially 
in women of early reproductive age [1, 2].
A B S T R A C T
The object of the study: Uterine fibroids (UF) in women of early reproductive age.
The problem to be solved: Improving the effectiveness of postoperative rehabilitation 
in women of early reproductive age with uterine fibroids based on the study of its morpho-
logical features and improvement of rehabilitation measures. 
The main scientific results: It was found that in women of early reproductive age with 
UF the most common complaints are posthemorrhagic anemia (61.0 %, or 61 women). Re-
garding the menstrual cycle, the most common dysmenorrhea – 26.0 % (in 26 women). The 
importance of heredity in the development of such pathology in young women (32.0 %, 
or 32 women) was confirmed. The most common localization of fibroids is interstitial – 
79.0 % (in 79 women).
Morphological study found that women of early reproductive age most often have a simple 
UF, namely 96 % (96 women). Uterine leiomyoma was present in 56 % (56 women). 
A study of the hormonal status of women of early reproductive age found that the mean 
values of hormones such as follicle-stimulating hormone (FSH), luteinizing hormone (LH), 
estradiol, progesterone, prolactin and testosterone were higher before surgery than after. 
When comparing rehabilitation methods (combined oral contraceptives (COCs) or gonad-
otropin-releasing hormone agonists (GnRH agonists), it was found that postoperative reha-
bilitation by using COCs for 6-12 months provides significantly better indicators of recov-
ery of hormonal status, indicating the effectiveness of rehabilitation method.
Scope of practical application of research results: Practical medicine specializing in the 
diagnosis, treatment and prevention of recurrence of uterine fibroids.
Innovative technological product: Improved algorithm of postoperative rehabilitation 
measures by applying COC for 6-12 months after myomectomy, which provides signifi-
cantly better results in restoring hormonal status during rehabilitation.
Scope of application of innovative technological product: clinical medical practice relat-
ed to the diagnosis, treatment and prevention of recurrence of uterine fibroids.
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For a long time, women with UF may have no complaints and find it by accident. The main 
complications that accompany UF are irregular, prolonged bleeding, anemia, chronic pelvic pain, repro-
ductive dysfunction, in particular, difficulty conceiving, miscarriage and infertility [3, 4].
There are a number of aspects that may be the causes of such pathology. These include hormonal, 
immunological, molecular genetic. In addition, factors that can trigger UF growth include age, race, 
obesity, pelvic infections, and lifestyle, namely alcohol consumption, smoking, constant stress, exces-
sive exercise, a diet depleted of vitamins, and so on [5].
The hormonal theory of UF development is hyperestrogenism, progesterone deficiency and hy-
pergonadotropism. In turn, the immunological theory of the pathogenesis of UF lies in the imbalance 
controlling the proliferative process of immune mechanisms, which can cause the development of such 
pathology, as well as accelerate the growth of fibroids [6, 7]. 
1. 3. Proposed way to solve the problem
Special attention is paid to the treatment of patients with UF, in particular, women of early re-
productive age, because this pathology adversely affects the reproductive function and general health 
of women. Such women should be treated as early as possible, immediately after diagnosis, because 
passive monitoring of them leads to disease progression. The main methods of therapy include hormonal 
and surgical treatment, with the latter becoming more and more common. Given the high frequency of 
recurrences and the desire of women to maintain reproductive function, treatment and prevention mea-
sures, as well as postoperative rehabilitation using hormonal correction to reduce recurrences are the 
basis of modern medicine. Therefore, the study of morphological features of UF and hormonal status 
before surgery and after hormonal correction in the postoperative period for rehabilitation is relevant.
The aim – improving the effectiveness of postoperative rehabilitation in women of early repro-
ductive age with uterine fibroids based on the study of its morphological features and improvement of 
rehabilitation measures. 
2. Materials and methods
The study was conducted from 2018 to 2020 on the basis of the Department of Obstetrics, Gy-
necology and Perinatology of the National Medical Academy of Postgraduate Education named after 
P. L. Shupyk on the basis of the Kyiv Maternity Hospital No. 1 (gynecological department). 150 women 
were selected for the study. Of these, 100 women under the age of 30 formed the main group (1), whose 
average age was 27.2±2.5 years. Inclusion criteria were age up to 30 years and the presence of UF with 
indications for surgical treatment. Exclusion criteria were age over 30 years, lack of UF, malignant neo-
plasms of the uterus. The other 50 women aged 40 to 50 years formed a control group (2). Their mean 
age was 45.5±3.7 years (P<0.05 relative to the main group). Inclusion criteria were age 40–50 years and 
the presence of UF with indications for surgical treatment. Exclusion criteria were age less than 40 years 
and more than 50 years, absence of UF, as well as malignant neoplasms of the uterus. 
The study collected a history of women with the presence of UF in relatives to determine 
the role of heredity in its development. In addition, their complaints were collected and analyzed, 
the general condition was assessed, a gynecological examination was performed, during which the 
cervix, vagina, uterine size were examined, and the presence of myomas, their number and size 
were determined. An ultrasound examination was also performed using an ultrasound machine 
“GE Logiq F8” (Germany). Abdominal scan (for large tumors) allowed to obtain screening infor-
mation about the condition of the uterus, the size and location of myomas, the relationship of nodes 
to adjacent organs, main vessels. Transvaginal scanning provided even more detailed information 
on the size and topography of the nodes.
Morphological studies were performed as follows: 3–4 fragments of tumor tissue and frag-
ments of the adjacent myometrium were taken from each myomatous node; the material was fixed 
in 10 % buffered formalin, then wired; paraffin sections 4 μm thick were stained with hematoxylin 
and eosin [8].
Also, in order to determine a more effective method of rehabilitation, in particular to reduce the 
recurrence rate of UF, the main group was divided into two subgroups: 1. 1 – 50 women who were pre-
scribed COC for 6–12 months, and 1. 2 – 50 women who took GnRH agonists for 3 months.
The hormonal status of the main group of women was assessed by determining hormones such 
as FSH, LH, estradiol, progesterone, prolactin and testosterone, electrochemiluminescent detection 
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(ECLIA) immunochemical method on a Sobas 6000 analyzer, using Roche Diagnost test systems (Swit-
zerland). To determine all hormonal parameters, venous blood was taken on day 5–7 of the menstrual 
cycle, except for progesterone, which was determined on day 20–21 of the menstrual cycle.
The study was conducted in accordance with the Declaration of Helsinki according to the con-
clusion of the Commission on Ethics of the National Medical Academy of Postgraduate Education 
named after P. L. Shupyk (minutes No. 3 from 11.01.2018). Informed consent to participate in the study 
was obtained from all women.
Statistical processing of the obtained data was performed using Statistica and Microsoft Office 
Excel. Evaluation of the statistical significance of the obtained data was performed using Student’s t-test 
and criterion X2, the differences were considered significant at p<0.05.
3. Results 
After analysis, it was found that the average duration of the disease in patients from the main 
group was 3.3±0.3 years, and the most frequent complaints according collected history were posthemor-
rhagic anemia (61.0 %, i.e. in 61 women), rapid growth of UF (51.0 %, i.e. in 51 women), pain syndrome 
(46.0 %, i.e. in 46 women), menstrual dysfunction (43.0 %, i.e. in 43 women), infertility (18.0 %, i.e. in 
18 women) and habitual miscarriage (10.0 %, i.e. in 10 women) [9].
Because menstrual dysfunction adversely affects a woman’s quality of life, on the one hand, 
and may be a factor in the development of other complications, including posthemorrhagic anemia, the 
frequency and nature of menstrual disorders in women of the main group were studied (Fig. 1). Thus, 
the most common dysmenorrhea – 26.0 % or 26 women (relative to oligomenorrhea and polymenorrhea 
p<0.05), less hypermenorrhea – 15 % or 15 patients, polymenorrhea – 11 % or 11 women, and the least 














Fig. 1. Frequency and nature of menstrual disorders in women of the main group: * regarding 
oligomenorrhea and polymenorrhea р<0.05
Given the important role in the development of UF plays heredity, so also in women of the 
main group was studied the aspect of heredity. Thus, 32.0 % of patients (ie, 32 women) (uterine fi-
broids under the age of 30) had a burdened heredity for the development of UF. Moreover, in 19.0 % 
of patients (ie 19 women) it was the first degree of kinship (fibroids in the mother or sister), in 5.0 % 
of women (ie 5 women) – the second degree (UF in the grandmother), in 6.0 % (ie 6 women) – III 
degree of kinship (aunt), 2.0 % (ie 2 women) – IV degree of kinship (cousin). The obtained data 
confirm the importance of genetic theory in the development of UF.
In addition, an important aspect is the localization of fibroids. During the ultrasound it 
was found that the most common interstitial nodes, namely in 79 women (79.0 %), in 24 wom-
en (24.0 %) there were subserous-interstitial nodes, interstitial with centrifugal growth were in 
22 women (22.0 %) and subserous in 17 women (17.0 %). In isolated cases, namely in 6 women 
(6.0 %) the presence of submucosal nodes was recorded.
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In order to determine the morphological type of UF and its features in women of early 
reproductive age, compared with UF in older women (control group), a morphological study was 
performed (Table 1).
Table 1
Morphological type of UF (%)
Indicators Main group n=100 Control group n=50
proliferating type of fibroids 4.0±1.96 6.0±4.59
mitotically active 1.0±0.99 2.0±2.77
cellular leiomyoma 3.0±1.70 4.0±3.83







leiomyoma with lymphoid infiltration 5.0±2.18 2.0±2.77
Note: for all indicators between the main and control groups р>0.05
It was found that proliferating and simple UF in the main group and control occurred with almost 
the same frequency: proliferating – respectively 4.0 and 6.0 % (i.e. in 4 and 3 women), simple – 96.0 and 
94.0 % (96 and 47 women). Leiomyoma was most common in these groups: in the main group in 56.0 % 
of women (in 56 women), and in the control group in 54.0 % (in 27 women). Vascular type of fibroids, 
on the contrary, was more common in women of the control group – 24.0 % (in 12 women), and in the 
main – 19.0 % (in 19 women). Mitotically active type was in 2.0 % of women (i.e. 1 woman) of the con-
trol group and 1.0 % (i.e. 1 woman) of the main. In addition, in the control group was recorded cellular 
leiomyoma in 4.0 % (in 2 women) of observations, in the main – in 3.0 % (in 3 women). There were also 
lipomatous – 2.0 % (in 1 woman) in women of the control group and 1.0 % (in 1 woman) in the main, 
chimeric and epithelioid – respectively, 3.0 % and 1.0 % (in 3 and 1 women) only in the main. The hy-
dropic type of fibroids was in 12.0 % (in 6 patients) in the control group and in 11.0 % (in 11 patients) in 
the main group. Leiomyoma with lymphoid infiltration was diagnosed in 2.0 % of women in the control 
group and in 5.0 % of the main group (i.e. in 1 and 5 women, respectively). 
The nature of disorders in myomatous nodes was also studied. It was found that patients of the 
main group, compared with the control, were significantly more likely to have microcirculation disor-
ders in the nodes – 43.0 % vs. 12.0 % (i.e., 43 and 6 women, respectively) (p<0.001) (Table ). Hyalinosis 
of nodes, on the contrary, was significantly more frequent in the control group – 44.0 % (in 22 women), 
i.e. in almost half of patients, while in the main – at 17.0 % (in 17 women) (p<0.001). Calcification of the 
nodes occurred with almost the same frequency in both groups (p>0.05).
In order to determine the hormonal characteristics of women of early reproductive age with UF, 
as well as the impact of myomectomy on them, their hormonal status before and after surgery (6 months 
after its implementation in phase 1 of the menstrual cycle) was studied. In order to determine a more 
effective method of postoperative rehabilitation – COC or GnRH agonists, a comparison of hormonal 
status between the respective subgroups was also performed.
Table 2
The nature of disorders in myomas (%)
Indicators Main group n=100 Control group n=50
microcirculatory disorders in the nodes (circulatory disorders, edema, necrosis) 43.0±4.95* 12.0±6.04
calcification of nodes 1.0±0.99 2.0±2.77
hyalinosis of nodes 17.0±3.75* 44.0±4.59
Note: * relative to the control group р<0.001
Data on the content of hormones in the blood of patients with UF before and 6 months after 
myomectomy are presented in Tables 3, 4.
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Table 3
Levels of FSH, LH, estradiol, progesterone, prolactin, testosterone in the blood of patients of early reproductive 
age with UF before and after myomectomy with COC rehabilitation
Indicators Before the operation main group n=100 After the operation subgroup 1. 1 n=50
FSH (MO/l) 7.9±0.8 6.5±0.5
LH (MO/l) 7.4±0.7 4.5±0.4*
Estradiol (pmol/l) 368.2±34.5 251.0±24.8*
Progesterone (nmol/l) 6.5±0.6 4.1±0.4*
Prolactin (mIU/l) 318.2±29.4 301.0±28.7
Testosterone (nmol/l) 2.2±0.2 1.6±0.2*
Note: * relative to the indicators of the main group before the operation р<0.05
Table 4
Levels of FSH, LH, estradiol, progesterone, prolactin, testosterone in the blood of patients of early reproductive 
age with UF before and after myomectomy with rehabilitation of GnRH agonists
Indicators Before the operation main group n=100 After the operation subgroup 1. 2 n=50
FSH (MO/l) 7.9±0.8 7.3±0.7
LH (MO/l) 7.4±0.7 5.1±0.7*
Estradiol (pmol/l) 368.2±34.5 327.8±30.5
Progesterone (nmol/l) 6.5±0.6 5.1±0.5
Prolactin (mIU/l) 318.2±29.4 311.0±27.5
Testosterone (nmol/l) 2.2±0.2 1.5±0.2*
Note: * relative to the indicators of the main group before the operation р<0.05
The presented data show that the average level of FSH before and after surgery was within 
normal values, but no significant effect of surgery was observed, including no significant differ-
ences between rehabilitation methods. At the same time, among women with COC rehabilitation, 
normal FSH levels were observed in 80.0 % (40 women) of cases and only in 20.0 % of patients (i.e. 
10 women) it exceeded the normative values, while among women with GnRH rehabilitation ago-
nists normal values of FSH levels after surgery were detected in 60.0 % of cases (in 30 women), and 
in 40.0 % (in 20 women) the FSH level exceeded the upper limit of normal. Regarding LH, after 
surgical treatment there was a statistically significant (P<0.05) decrease in its level, and there was 
an increase in the number of women with normal values to 84.0 % (42 women). At the same time, 
there was no significant difference in approaches to postoperative rehabilitation.
In turn, the mean values of estradiol after surgery showed a significant decrease (p<0.05) 
in women with COC rehabilitation (normal values were in 84.0 % of patients, namely in 42 pa-
tients), in contrast to the rehabilitation of GnRH agonists, when the differences between the mean 
values of this hormone before and after myomectomy did not differ significantly (indicators after 
surgery in 68.0 % of women, i.e. in 34 patients, were within normal limits).
A similar situation occurred for progesterone, when COC rehabilitation provided better re-
sults, namely a statistically significant decrease after myomectomy of the average value of this 
hormone (p<0.05), while among women with GnRH agonists rehabilitation, although there was a 
decrease in its average level but it was insignificant.
The average values of prolactin before and after surgery did not differ significantly, while the 
average level of testosterone, on the contrary, after myomectomy differed significantly in the direc-
tion of decrease (p<0.05), which indicates the effectiveness of such treatment. However, there was no 
statistically significant difference directly between rehabilitation methods in terms of this hormone.
Therefore, from the analysis it is possible to observe higher efficiency of postoperative rehabil-
itation by use of COC (average values of LH, estradiol, progesterone and testosterone after operation 
and COC rehabilitation were significantly better than before myomectomy). Rehabilitation of GnRH 
agonists provides a slightly smaller effect, although, in general, also brings positive results (average 
values of LH and testosterone after myomectomy with rehabilitation of GnRH agonists were signifi-
cantly better than before surgery). 
4. Discussion of research results
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The occurrence of UF, especially in early reproductive age, remains one of the main prob-
lems of modern medicine, because the complications it causes, especially infertility, affect not only 
a woman’s reproductive health, but also her psychological state [10, 11]. According to the literature, 
the main risk factors for such pathology include chronic genital and extragenital diseases, bad habits, 
environmental hazards, frequent stress, irrational use of contraceptives and others. For early diagno-
sis of uterine fibroids in women of early reproductive age should pay attention to the implementation 
of reproductive function, heredity and the nature of the formation of menstrual function [12, 13].
It is known that, especially in early reproductive age, UF is characterized by various clinical 
manifestations [14, 15]. It was found that the most common such manifestations were posthemorrhag-
ic anemia, pain, menstrual dysfunction, infertility and habitual miscarriage. In terms of menstrual 
disorders, it was found that in women of early reproductive age the most common dysmenorrhea – 
26.0 % (in 26 women), and the least - oligomenorrhea, which, despite the presence of UF, was ob-
served in 7.0 % of patients (in 7 women) of the main group.
Heredity plays an important role in the development of UF [16]. The results showed that some 
of the studied women of early reproductive age were burdened with heredity in the development of 
UF (32.0 %, or 32 women), in particular in one in five – 19.0 % (19 women) – the first degree of kin-
ship (mother, sister). The obtained data once again confirmed the importance of genetic theory in its 
development.
Another aspect of a disease such as UF is its adverse effects on a woman’s reproductive health. 
In this context, its location plays an important role [17, 18]. When assessing the structure of localiza-
tion of myomatous nodes in patients of the main group, it was found that interstitial nodes occurred 
in 79.0 % of cases (in 79 women), subserous-interstitial – in 24.0 % (in 24 women), interstellar with 
centrifugal growth – in 22.0 % (in 22 women), subserous – in 17.0 % (in 17 women), submucosal – in 
6.0 % (in 6 women).
Regarding the morphological structure, the most common simple type of fibroids: in the main 
group – 96 % (96 women), in the control – 94 % (47 women). Among them, leiomyoma was most of-
ten detected: in the main group – 56 % (in 56 women), in the control – 54 % (in 27 women). It was also 
found that women in the main group, compared with the control, significantly more common micro-
circulation disorders in the nodes (43.0 % vs. 12.0 %, i.e. in 43 and 6 women, respectively, p<0.001), 
and hyalinosis nodes, on the contrary, – in 17.0 % in the main group against 44 % in the control group 
(i.e. in 17 and 22 women, respectively, p<0.001).
It is known that one of the main methods of treatment is surgery. However, its effectiveness 
against relapses in the future depends on the right hormonal correction [19, 20]. Therefore, the hor-
monal status of women of early reproductive age was investigated and analyzed in order to determine 
a more optimal method of rehabilitation. The data showed that among women with COC rehabil-
itation in more patients normal FSH levels were observed, and only in 20.0 % of patients (i.e. in 
10 women) it exceeded the norm, while among women with GnRH agonists rehabilitation there was 
some the number of women with normal values – 60.0 % (30 women) with 40.0 % (20 women) with 
exceeding the upper limit of its norm. Regarding LH, there was no significant difference in approach-
es to postoperative rehabilitation. The mean values of estradiol and progesterone were significantly 
better in women with COC rehabilitation, in contrast to the other subgroup, where although there was 
a decrease in their mean values compared to myomectomy, but such a decrease was insignificant. The 
results also showed that in women of both the first subgroup and the second prolactin did not differ 
statistically before and after surgery. The picture of testosterone showed significantly better averages 
after rehabilitation by both methods.
Study limitations. The study was not performed in case of severe extragenital pathology. 
Prospects for further research. Establishing the recurrence rate of uterine fibroids in wom-
en of early reproductive age among those receiving COC and GnRH agonists as rehabilitation, and 
determining the correlation between recurrence rate and reproductive function in women with these 
rehabilitation methods.
Study of the features of recurrence of uterine fibroids in women of early reproductive age in 
order to increase their reproductive function. 
5. Conclusions
As a result of a study in women of early reproductive age with UF was found:
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1. The most frequent complaints are posthemorrhagic anemia (61.0 %, i.e. in 61 women); men-
strual disorders are most often characterized by dysmenorrhea – 26.0 % (in 26 women).
2. The most common localization of fibroids is interstitial – 79.0 % (in 79 women).
3. By morphological type, simple UF is most common, namely 96 % (in 96 women), with the 
frequency of uterine leiomyoma – 56 % (in 56 women); impaired microcirculation in the nodes was 
in 43 % (43 women).
4. Mean values of hormones such as FSH, LH, estradiol, progesterone, prolactin and testoster-
one were higher before surgery than after with appropriate rehabilitation.
5. Postoperative rehabilitation by using COC for 6–12 months after myomectomy provides 
significantly better results in restoring hormonal status (LH, estradiol, progesterone and testosterone), 
which indicates a higher efficiency of this method of rehabilitation, compared with GnRH agonists.
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